• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-Beta Galactosidase

Beta Galactosidase Monoclonal Antibody for WB, IHC, IF/ICC, Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, rat, souris

Applications

WB, IHC, IF/ICC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

4F4F4

N° de cat : 66586-1-PBS

Synonymes

GLB1, 4F4F4, Acid beta-galactosidase, Beta-galactosidase, EBP



Informations sur le produit

66586-1-PBS cible Beta Galactosidase dans les applications de WB, IHC, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène Beta Galactosidase Protéine recombinante Ag8069
Nom complet galactosidase, beta 1
Masse moléculaire calculée 76 kDa
Poids moléculaire observé 64-66 kDa, 76-85 kDa
Numéro d’acquisition GenBankBC007493
Symbole du gène GLB1/Beta-galactosidase
Identification du gène (NCBI) 2720
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

GLB1(Beta-galactosidase) is also named as ELNR1 or Lactase. It cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans. This protein is identical to the elastin-binding protein (EBP), a major component of the nonintegrin cell surface receptor complex expressed in fibroblasts, smooth muscle cells, chondroblasts, leukocytes, and certain cancer cell types. Defects in GLB1 are the cause of GM1-gangliosidosis type 1 (GM1G1), GM1-gangliosidosis type 2 (GM1G2), GM1-gangliosidosis type 3 (GM1G3) and mucopolysaccharidosis type 4B (MPS4B). GBL1 is synthesized as an 85-kDa precursor that is C-terminally processed into a 64-66 kDa mature form and the released ~20-kDa proteolytic fragment was thought to be degraded (PMID: 10744681). GLB1 has 3 isoforms with MW of 76 kDa, 73 kda and 61 kDa.

{{ptg:RelatedPrimaryAntibodies}}